" The proposed combination of Pfizer and Allergan will create a leading global pharmaceutical company with the strength to research , discover and deliver more medicines and therapies to more people around the world , " Read said in a statement . " Allergan ' s businesses align with and enhance Pfizer ' s businesses , creating best in class , sustainable , innovative and established businesses that are poised for growth . Through this combination , Pfizer will have greater financial flexibility that will facilitate our continued discovery and development of new innovative medicines for patients , direct return of capital to shareholders , and continued investment in the United States , while also enabling our pursuit of business development opportunities on a more competitive footing within our industry . "
